CLINICAL TRIAL OF THE VEDERA KXS MICROWAVE SYSTEM WITH CORNEAL COLLAGEN CROSSLINKING (KERAFLEX) COMPARED WITH CORNEAL COLLAGEN CROSSLINKING ALONE
Please enjoy this video of Dr. Peter Hersh narrating a Keraflex procedure in Istanbul
Dr. Hersh and the CLEI Center for Keratoconus are pleased to announce a new clinical trial of the The Vedera KXS Microwave System with Corneal Collagen Crosslinking (Keraflex). This study compares this treatment to corneal collagen crosslinking alone. All patients in the study will be randomly assigned to one of two treatment groups (either Keraflex and Crosslinking, or Crosslinking alone). Keraflex is a non-incisional procedure designed to flatten the cornea in keratoconus. During the Keraflex procedure, the Vedera KXS delivers a single low energy microwave pulse lasting less than a second. The energy is applied to the cornea using a microwave emitter which contacts the surface of the cornea. This raises the temperature of the selected region of the cornea, shrinking the collagen and forming either a a circular or semicircular application spot in the upper region of the cornea around the keratoconic cone. This results in reshaping of the cornea, with the goal of flattening the cone in keratoconus. The Keraflex procedure is done using a topical anesthetic drop for comfort. In the corneal collagen crosslinking procedure, the surface epithelial cells are first removed and riboflavin drops are then administered. This is followed by UV light application. Generally, a contact lens bandage is applied to aid in healing and comfort after the procedure.